The vaccine has been developed by the University of Oxford and is only the second malaria vaccine to be developed. Malaria kills mostly babies and infants, and has been one of the biggest scourges ...

Vaccines against malaria have been the object of constant endeavor by the scientific community and pharmaceutical industries for over three decades, with little success so far. Hopes for ...

Aug. 11, 2023 — An experimental malaria vaccine appears safe and promotes an immune response in African infants, one of the groups most vulnerable to severe malaria disease. There is currently ...

Scientists at La Trobe University have discovered a new antibody-like molecule that could be used in therapy to prevent ...

Vaccine efficacy against infection with malaria parasites in the lower dose group was as high or higher during the second year (61%) as during the first year, without boosting, a first for a ...

A recent study published in the journal Nature Reviews Microbiology reviewed malaria vaccines and their successes and failures. Nearly half of the world’s population is at risk of malaria ...

The vaccine showed 49% to 57% efficacy among women who became pregnant after vaccination during a two-year trial period, ...

the second of its kind, would pave the way for a “really serious” attempt at eradicating the disease. The vaccine, which has been hailed as a scientific breakthrough, is the first malaria ...

Vaccine efficacy against infection with malaria parasites in the lower dose group was as high or higher during the second year (61%) as during the first year, without boosting, a first for a ...

Malaria, a longstanding and life-threatening disease, contributes to approximately 249 million global cases.1 Plasmodium ...

Malaria continues to be a leading cause of illness and death in South Sudan, particularly among young children. In 2022, the country reported an estimated 2.8 million cases and 6,680 deaths. About ...

Background image of malaria parasites with foreground photo montage showing infected red blood cell, mosquito, and vaccine vial. Two National Institutes of Health (NIH)-supported trials of an ...